Recombinant Breast Carcinoma Amplified Sequence 2 (BCAS2)
Cat#:TP01302应用:Positive Control; Immunogen; SDS-PAGE; WB
| Product Name: | BCAS2 Rabbit pAb |
| Cat No.: | DPA04309 |
| Clonality: | Polyclonal |
| Species Reactivity: | Human, Mouse, Rat |
| Tested Applications: | WB,ICC/IF,IP |
| Recommended Dilution: | WB: 1:1000-1:5000 ICC/IF: 1:50-1:200 IP: 1:20-1:50 |
| Size: | 30ul 50ul 100uL |
| Format: | Liquid |
| Source: | Rabbit |
| Purification Method: | Affinity Purification |
| Isotype: | IgG |
| Conjugate: | Un-conjugated |
| Storage: | Store at -20°C. Supplied in 50nM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide a |
| Immunogen: | A synthetic peptide of human BCAS2 |
| Calculated Molecular Weight: | 26 kDa |
| Observed Molecular Weight: | 26 kDa |
| GenBank Accession Number: | O75934 |
| Gene ID (NCBI): | 10286 |
| Synonyms: | DAM1; SPF27; Snt309 |
| Background: | Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex. The PRP19-CDC5L complex may also play a role in the response to DNA damage (DDR). |
| Category: | Primary Ab |